From evidence-based medicine to genomic medicine

Genomic Medicine

Volumn 1, Issue 3-4, 2007, Pages 95-104

  Kumar, Dhavendra ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Evidence based medicine; Genetics; Genomic medicine; Genomics; Nutrigenomics; Personalised medicine; Pharmacogenetics; Pharmacogenomics

Indexed keywords

EID: 41149179670     PISSN: 18717934     EISSN: 18717942     Source Type: Journal    
DOI: 10.1007/s11568-007-9013-6     Document Type: Review

References (43)

1. British Medical Association (1995) Report of the working group on medical education. BMA, London
2. British Medical Journal (1996) Editorial: evidence based medicine: what it is and what is isn't. Br Med J 312:71-72
3. Contopolous-Ionnidis JP, Ntzami E, Ionnidis JP (2003) Translation of highly promising basic science research into clinical applications. Am J Med 114:477-484
4. Davidoff F, Haynes B, Sackett D, Smith R (1995) Evidence based medicine: a new journal to help doctors identify the information they need. BMJ 310:1085-1086
5. Davis CD, Milner J (2004) Frontiers in nutrigenomics, proteomics, metabolomics and cancer prevention. Mutat Res 551(1-2):51-64
6. Donaldson LJ, Donaldson RJ (2003). Essential public health, 2nd edn (revised). Petroc Press, pp 204-206
7. Eccles M, Freemantle N, Mason J (1998) North of England evidence based guideline development project: summary guideline for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis. The North of England Non-Steroidal Anti-Inflammatory Drug Guideline Development Group. BMJ 317(7157):526-530
8. Evidence-Based Medicine Working Group (1992) Evidence-based medicine: a new approach to teaching the practice of medicine. JAMA 268:2420-2425
9. Fierz W (2004) Challenge of personalized health care: to what extent is medicine already individualized and what are the future trends? Med Sci Monit 10(5):RA111-RA123
10. Garrard C, Hinds C, Knight J (2007) Applications in critical care medicine. In: Kumar D (ed) Genomics and clinical medicine. Oxford University Press, New York
11. General Medical Council (1994) Education committee report. GMC, London
12. Go VLW, Wong DA, Wang Y, Butrum RR, Norman HA, Wilkerson LA (2004) Diet and cancer prevention: evidence-based medicine to genomic medicine. J Nutr 134:3513S-3516S
13. Go VLW, Nguyen CTH, Harris DM, Lee W-N (2005) Nutrient-gene interaction: metabolic genotype-phenotype relationship. J Nutr 135:3016S-3020S
14. Grahame-Smith D (1995) Evidence-based medicine: socratic dissent. BMJ 310:1126-1127
15. Guyatt GH (1991) Evidence-based medicine (editorial). ACP J Club 114:A16
16. Harris DM, Go VLW (2005) How dietary components protect from cancer. In: Awad AB, Bradford PG (eds) Nutrition and cancer prevention. Marcel Dekkar, Inc., New York, pp 27-58
17. Haynes RB (2002) What kind of evidence is it that evidence-based medicine advocates want health care providers and consumers to pay attention to? BMC Health Serv Res 2:3-9
18. House of Commons Health Committee (1995) Priority setting in the NHS: purchasing. First report sessions 1994-1995. HMSO, London (HC134-1)
19. Johnson JA (2003) Pharmacogenomis: potential for individualized drug therapy through genetics. Trends Genet 19:660-666
20. Johnson JA, Cavallari LH (2005) Cardiovascular pharmacogenomics. Exp Physiol 90(3):283-289
21. Jukema JW (1999) Matching treatment to the genetic basis of (lipid) disorder in patients with coronary artery disease. Heart 82:126-127
22. Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L (2007) The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genetic Med 9(10):665-674
23. Kuivenhoven JA, Jukema JW, Zwinderman AH et al (1998) The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. N Eng J Med 338:86-93
24. Kumar D (2007) Genomic medicine: a new frontier of medicine in the twenty first century. Genomic Med 1&2:3-7
25. Lancet (1995) Correspondence. Evidence-based medicine. Lancet 346:1171-1172
26. Lenfant C (2003) Shattuck lecture: clinical research to clinical practice-lost in translation? N Eng J Med 349:868-874
27. 2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest 102:1534-1539
28. Nevins JR, Huang ES, Dressman H, Pittman J, Huang AT, West M (2003) Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction. Human Mole Genet 12:R153-R157
29. Peacock C, Jamiesson S (2007) Infectious diseases: susceptibility, resistance, response, and anti-microbial therapy. In: Kumar D (ed) Genomics and clinical medicine. Oxford University Press, New York
30. Penny M, McHale D (2007) Pharmacogenomics: drug development, drug response and precision medicines. In: Kumar D (ed) Genomics and clinical medicine. Oxford University Press, New York
31. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang C et al (2001) Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA 98:15149-15154
32. Sackett DL, Strus SE, Richardson WS, Rosenberg WMC, Haynes RB (2000) Evidence-based medicine: how to practice and teach EBM, 2nd edn. Harcourt Brace, Edinburgh
33. Scriver CR et al (eds) (2001) The metabolic and molecular bases of inherited diseases, 7th edn. McGraw-Hill, New York
34. Singh D, Febbo PG, Ross K, Jackson DG, Manola J et al (2002) Gene expression correlates of clinical prostate cancer behaviour. Cancer Cell 1:203-209
35. Standing Committee on Post-graduate Medical Education (SCOPME) (1994) Creating a better learning environment in hospitals. 1. Teaching hospital doctors and dentists to teach. SCOPME, London
36. van de Vijver MJ, He YD, van'T Veer LJ, Dai H et al (2002) A gene-expression signature as a predictor of survival in breast cancer. New Eng J Med 347:1999-2009
37. van'T Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536
38. Weatherall DJ (1994) The inhumanity of medicine. BMJ 309:1671-1672
39. Weatherall DJ (2006) Genomics and world health: hopes and realities. J Zhejiang Univ 7(2):161
40. West M, Blachette C, Dressman H, Huang E, Ishida S et al (2001) Predicitng the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA 98:11462-11467
41. West M, Ginsburg GE, Huang AT, Nevins JR (2006) Embracing the complexity of genomic data for personalized medicine. Genome Res 16:559-566
42. Wilkins MR, Roses AD, Clifford CP (2000) Pharmcogenetics and the treatment of cardiovascular disease. Heart 84:353-354
43. Zeisel SH, Freake HC, Bauman DE, Bier DM, Burrin DG, German JB et al (2005) The nutritional phenotype in the age of metabolomics. J Nutr 135(7):13-16